TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Astellas Pharma AB
Closing information (x1000 EUR)
| Closing information | 2024/03 | 2023/03 | 2022/03 |
| Turnover |
3,298
|
3,885
|
3,980 |
| Financial expenses |
6
|
14
|
70 |
| Earnings before taxes |
75
|
177
|
142 |
| EBITDA |
51
|
191
|
146 |
| Total assets |
6,177
|
4,975
|
4,374 |
| Current assets |
6,177
|
4,975
|
4,374 |
| Current liabilities |
2,689
|
1,621
|
1,051 |
| Equity capital |
3,488
|
3,354
|
3,324 |
| - share capital |
22
|
22
|
22 |
| Employees (average) |
16
|
16
|
18 |
Financial ratios
| Fiscal year | 2024/03 | 2023/03 | 2022/03 |
| Solvency |
56.5%
|
67.4%
|
76.0% |
| Turnover per employee |
206
|
243
|
221 |
| Profit as a percentage of turnover |
2.3%
|
4.6%
|
3.6% |
| Return on assets (ROA) |
1.3%
|
3.8%
|
4.8% |
| Current ratio |
229.7%
|
306.9%
|
416.2% |
| Return on equity (ROE) |
2.2%
|
5.3%
|
4.3% |
| Change turnover |
-503
|
235
|
-665 |
| Change turnover % |
-13%
|
6%
|
-14% |
| Chg. No. of employees |
0
|
-2
|
-1 |
| Chg. No. of employees % |
0%
|
-11%
|
-5% |
Total value of public sale
| Fiscal year | 2024/03 | 2023/03 | 2022/03 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.